One in seven men in Australia is at risk of developing prostate cancer before the age of 75. This disease is a leading cause of male death worldwide, with a mortality rate of 62 men per 100,000. Treatments for prostate ...

The standard of care for locally advanced rectal cancer (T3-4 +/- N+) is neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision (TME). However, this has been challenged recently with increasing interest ...

Breast cancer (BC) is one of the most prevalent cancer types and second leading cause of cancer death among Australian women. BC is a genetically heterogeneous disease, divided into sub-types that differ in their aggressiveness, ...

Adoptive cell therapy using chimeric antigen receptor (CAR) T cells has shown great success in haematological malignancies, leading to recent approval of two CD19-specific CAR T cell products by the Food and Drug Administration ...

Malignant pleural mesothelioma (MPM) is a rare but deadly malignancy. Despite predictions, worldwide incidences have not significantly diminished and available therapeutic modalities have failed to improve outcomes. There ...

In Victoria, rural patients with colorectal cancer have poorer outcomes than urban counterparts. To date, research and policy initiatives have focused on addressing potential variation in cancer treatment. However, ...